1.GSK
GSK.L (LSE)
GSK stands out as a defensive pharmaceutical stock, making it an appealing choice for investors seeking stability amid economic uncertainties. With a current dividend yield of 2.77% and impressive returns of 38.75% over the past year and 55.02% over five years, it showcases the resilience of healthcare demand during recessions. However, recent analyst ratings indicate a more cautious outlook, with downgrades from both SVB Leerink and Deutsche Bank, suggesting investors remain vigilant.
Pros:
- Strong performance in healthcare demand
- Robust dividend yield
Cons:
- Market volatility risk
- Dependence on pharmaceutical sector performance
2.Tesco
TSCO.L (LSE)
Tesco stands out as a resilient supermarket retailer that is successfully navigating economic challenges, maintaining strong foot traffic while upgrading its profit guidance. With a dividend yield of 3.20% and a solid 1-year return of 38.23%, it presents an appealing risk/reward scenario for investors. Bernstein rates the stock as "Outperform," suggesting it remains a valuable option for those seeking stable returns in the current market landscape.
Pros:
- Strong revenue growth
- Resilient business model
Cons:
- Moderate near-term growth outlook
- Economic pressures affecting retail sector
3.Supermarket Income REIT
SUPR.L (LSE)
Supermarket Income REIT, a FTSE 250 company, specializes in supermarket properties, making it a strong contender for investors seeking resilient income even during economic downturns. With a solid dividend yield of 7.35% and a balanced analyst perspective featuring 3 buy and 3 hold ratings, this REIT demonstrates cautious optimism for future performance. Despite a challenging 5-year return of -27.74%, the REIT's focus on essential retail demand positions it well in the current market landscape.
Pros:
- High dividend yield
- Stable income from essential retail properties
Cons:
- Negative performance over five years
- Market sentiment affecting real estate valuations
Final Words
As you consider your investment strategy in April 2026, keep in mind the potential stability of recession-proof stocks like GSK, which offer both growth and dividends. Take time to compare your options and conduct thorough research to make informed decisions that align with your financial goals.
Frequently Asked Questions
GSK is considered a top recession-proof stock due to its strong demand in the healthcare sector, which remains stable even during economic downturns. Additionally, it is trading at 14 times earnings and offers a 2.77% dividend yield, appealing to conservative investors.
As of April 2026, GSK offers a dividend yield of 2.77%, with dividends distributed quarterly. This consistent yield makes it attractive for income-focused investors.
GSK has shown robust performance with a 1-year return of 38.75%. This performance highlights its resilience and potential for growth even in challenging economic conditions.
While GSK is a defensive stock, risks include potential regulatory changes and market competition in the pharmaceutical sector. Investors should consider these factors and conduct thorough research before investing.
GSK stands out among healthcare stocks due to its diversified portfolio in pharmaceuticals, vaccines, and consumer healthcare products. Its strong market cap of $82 billion and consistent dividend payments further enhance its appeal compared to peers.
Before investing in recession-proof stocks, consider your risk tolerance, the stock's historical performance, and its sector stability during economic downturns. Diversifying your investments across different sectors can also help mitigate risks.
